Coronavirus disease-2019 and the intestinal tract: An overview
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can progress to a severe respiratory and systemic disease named coronavirus disease-2019 (COVID-19). The most common symptoms are fever and respiratory discomfort. Nevertheless, gastrointestinal infections have been reported, wit...
Gespeichert in:
| Veröffentlicht in: | World journal of gastroenterology : WJG 2021-04, Vol.27 (13), p.1255-1266 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1266 |
|---|---|
| container_issue | 13 |
| container_start_page | 1255 |
| container_title | World journal of gastroenterology : WJG |
| container_volume | 27 |
| creator | Alberca, Gabriela Gama Freire Solis-Castro, Rosa Liliana Solis-Castro, Maria Edith Alberca, Ricardo Wesley |
| description | Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can progress to a severe respiratory and systemic disease named coronavirus disease-2019 (COVID-19). The most common symptoms are fever and respiratory discomfort. Nevertheless, gastrointestinal infections have been reported, with symptoms such as diarrhea, nausea, vomiting, abdominal pain, and lack of appetite. Importantly, SARS-CoV-2 can remain positive in fecal samples after nasopharyngeal clearance. After gastrointestinal SARS-CoV-2 infection and other viral gastrointestinal infections, some patients may develop alterations in the gastrointestinal microbiota. In addition, some COVID-19 patients may receive antibiotics, which may also disturb gastrointestinal homeostasis. In summary, the gastrointestinal system, gut microbiome, and gut-lung axis may represent an important role in the development, severity, and treatment of COVID-19. Therefore, in this review, we explore the current pieces of evidence of COVID-19 gastrointestinal manifestations, possible implications, and interventions. |
| doi_str_mv | 10.3748/wjg.v27.i13.1255 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8015300</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2511246551</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-ac2b90952c471e51cb5f77b3abe0893a9cf0e4ce92fcda2468e64fc0a8b5a7bb3</originalsourceid><addsrcrecordid>eNpVkD1PwzAQhi0EoqWwM6GMLClnO25ihkpVxZdUiQVmy3Euras0KXaSin-Pq5YKphvu3o97CLmlMOZpkj3s1stxz9KxpXxMmRBnZMgYlTHLEjgnQwqQxpKzdECuvF8DMM4FuyQDzjPOkwyGZDpvXFPr3rrOR4X1qD3GDKiMdF1E7QojW7foW1vrKmqdNu1jNKujpkfXW9xdk4tSVx5vjnNEPp-fPuav8eL95W0-W8SGy0kba8NyCVIwk6QUBTW5KNM05zpHyCTX0pSAiUHJSlNolkwynCSlAZ3lQqd5zkdkevDddvkGC4N16FKprbMb7b5Vo636v6ntSi2bXmVABQcIBvdHA9d8deEhtbHeYFXpGpvOKyYoDblC0HAKh1PjGu8dlqcYCmqPXQXsKmBXAbvaYw-Su7_1ToJfzvwHBXyAcA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2511246551</pqid></control><display><type>article</type><title>Coronavirus disease-2019 and the intestinal tract: An overview</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Alberca, Gabriela Gama Freire ; Solis-Castro, Rosa Liliana ; Solis-Castro, Maria Edith ; Alberca, Ricardo Wesley</creator><creatorcontrib>Alberca, Gabriela Gama Freire ; Solis-Castro, Rosa Liliana ; Solis-Castro, Maria Edith ; Alberca, Ricardo Wesley</creatorcontrib><description>Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can progress to a severe respiratory and systemic disease named coronavirus disease-2019 (COVID-19). The most common symptoms are fever and respiratory discomfort. Nevertheless, gastrointestinal infections have been reported, with symptoms such as diarrhea, nausea, vomiting, abdominal pain, and lack of appetite. Importantly, SARS-CoV-2 can remain positive in fecal samples after nasopharyngeal clearance. After gastrointestinal SARS-CoV-2 infection and other viral gastrointestinal infections, some patients may develop alterations in the gastrointestinal microbiota. In addition, some COVID-19 patients may receive antibiotics, which may also disturb gastrointestinal homeostasis. In summary, the gastrointestinal system, gut microbiome, and gut-lung axis may represent an important role in the development, severity, and treatment of COVID-19. Therefore, in this review, we explore the current pieces of evidence of COVID-19 gastrointestinal manifestations, possible implications, and interventions.</description><identifier>ISSN: 1007-9327</identifier><identifier>ISSN: 2219-2840</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v27.i13.1255</identifier><identifier>PMID: 33833480</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>COVID-19 ; Gastrointestinal Diseases - therapy ; Gastrointestinal Microbiome ; Humans ; Review ; SARS-CoV-2</subject><ispartof>World journal of gastroenterology : WJG, 2021-04, Vol.27 (13), p.1255-1266</ispartof><rights>The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.</rights><rights>The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. 2021</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-ac2b90952c471e51cb5f77b3abe0893a9cf0e4ce92fcda2468e64fc0a8b5a7bb3</citedby><cites>FETCH-LOGICAL-c396t-ac2b90952c471e51cb5f77b3abe0893a9cf0e4ce92fcda2468e64fc0a8b5a7bb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015300/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015300/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33833480$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alberca, Gabriela Gama Freire</creatorcontrib><creatorcontrib>Solis-Castro, Rosa Liliana</creatorcontrib><creatorcontrib>Solis-Castro, Maria Edith</creatorcontrib><creatorcontrib>Alberca, Ricardo Wesley</creatorcontrib><title>Coronavirus disease-2019 and the intestinal tract: An overview</title><title>World journal of gastroenterology : WJG</title><addtitle>World J Gastroenterol</addtitle><description>Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can progress to a severe respiratory and systemic disease named coronavirus disease-2019 (COVID-19). The most common symptoms are fever and respiratory discomfort. Nevertheless, gastrointestinal infections have been reported, with symptoms such as diarrhea, nausea, vomiting, abdominal pain, and lack of appetite. Importantly, SARS-CoV-2 can remain positive in fecal samples after nasopharyngeal clearance. After gastrointestinal SARS-CoV-2 infection and other viral gastrointestinal infections, some patients may develop alterations in the gastrointestinal microbiota. In addition, some COVID-19 patients may receive antibiotics, which may also disturb gastrointestinal homeostasis. In summary, the gastrointestinal system, gut microbiome, and gut-lung axis may represent an important role in the development, severity, and treatment of COVID-19. Therefore, in this review, we explore the current pieces of evidence of COVID-19 gastrointestinal manifestations, possible implications, and interventions.</description><subject>COVID-19</subject><subject>Gastrointestinal Diseases - therapy</subject><subject>Gastrointestinal Microbiome</subject><subject>Humans</subject><subject>Review</subject><subject>SARS-CoV-2</subject><issn>1007-9327</issn><issn>2219-2840</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkD1PwzAQhi0EoqWwM6GMLClnO25ihkpVxZdUiQVmy3Euras0KXaSin-Pq5YKphvu3o97CLmlMOZpkj3s1stxz9KxpXxMmRBnZMgYlTHLEjgnQwqQxpKzdECuvF8DMM4FuyQDzjPOkwyGZDpvXFPr3rrOR4X1qD3GDKiMdF1E7QojW7foW1vrKmqdNu1jNKujpkfXW9xdk4tSVx5vjnNEPp-fPuav8eL95W0-W8SGy0kba8NyCVIwk6QUBTW5KNM05zpHyCTX0pSAiUHJSlNolkwynCSlAZ3lQqd5zkdkevDddvkGC4N16FKprbMb7b5Vo636v6ntSi2bXmVABQcIBvdHA9d8deEhtbHeYFXpGpvOKyYoDblC0HAKh1PjGu8dlqcYCmqPXQXsKmBXAbvaYw-Su7_1ToJfzvwHBXyAcA</recordid><startdate>20210407</startdate><enddate>20210407</enddate><creator>Alberca, Gabriela Gama Freire</creator><creator>Solis-Castro, Rosa Liliana</creator><creator>Solis-Castro, Maria Edith</creator><creator>Alberca, Ricardo Wesley</creator><general>Baishideng Publishing Group Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210407</creationdate><title>Coronavirus disease-2019 and the intestinal tract: An overview</title><author>Alberca, Gabriela Gama Freire ; Solis-Castro, Rosa Liliana ; Solis-Castro, Maria Edith ; Alberca, Ricardo Wesley</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-ac2b90952c471e51cb5f77b3abe0893a9cf0e4ce92fcda2468e64fc0a8b5a7bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>COVID-19</topic><topic>Gastrointestinal Diseases - therapy</topic><topic>Gastrointestinal Microbiome</topic><topic>Humans</topic><topic>Review</topic><topic>SARS-CoV-2</topic><toplevel>online_resources</toplevel><creatorcontrib>Alberca, Gabriela Gama Freire</creatorcontrib><creatorcontrib>Solis-Castro, Rosa Liliana</creatorcontrib><creatorcontrib>Solis-Castro, Maria Edith</creatorcontrib><creatorcontrib>Alberca, Ricardo Wesley</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alberca, Gabriela Gama Freire</au><au>Solis-Castro, Rosa Liliana</au><au>Solis-Castro, Maria Edith</au><au>Alberca, Ricardo Wesley</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coronavirus disease-2019 and the intestinal tract: An overview</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World J Gastroenterol</addtitle><date>2021-04-07</date><risdate>2021</risdate><volume>27</volume><issue>13</issue><spage>1255</spage><epage>1266</epage><pages>1255-1266</pages><issn>1007-9327</issn><issn>2219-2840</issn><eissn>2219-2840</eissn><abstract>Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can progress to a severe respiratory and systemic disease named coronavirus disease-2019 (COVID-19). The most common symptoms are fever and respiratory discomfort. Nevertheless, gastrointestinal infections have been reported, with symptoms such as diarrhea, nausea, vomiting, abdominal pain, and lack of appetite. Importantly, SARS-CoV-2 can remain positive in fecal samples after nasopharyngeal clearance. After gastrointestinal SARS-CoV-2 infection and other viral gastrointestinal infections, some patients may develop alterations in the gastrointestinal microbiota. In addition, some COVID-19 patients may receive antibiotics, which may also disturb gastrointestinal homeostasis. In summary, the gastrointestinal system, gut microbiome, and gut-lung axis may represent an important role in the development, severity, and treatment of COVID-19. Therefore, in this review, we explore the current pieces of evidence of COVID-19 gastrointestinal manifestations, possible implications, and interventions.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>33833480</pmid><doi>10.3748/wjg.v27.i13.1255</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1007-9327 |
| ispartof | World journal of gastroenterology : WJG, 2021-04, Vol.27 (13), p.1255-1266 |
| issn | 1007-9327 2219-2840 2219-2840 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8015300 |
| source | MEDLINE; Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
| subjects | COVID-19 Gastrointestinal Diseases - therapy Gastrointestinal Microbiome Humans Review SARS-CoV-2 |
| title | Coronavirus disease-2019 and the intestinal tract: An overview |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T18%3A05%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coronavirus%20disease-2019%20and%20the%20intestinal%20tract:%20An%20overview&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Alberca,%20Gabriela%20Gama%20Freire&rft.date=2021-04-07&rft.volume=27&rft.issue=13&rft.spage=1255&rft.epage=1266&rft.pages=1255-1266&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v27.i13.1255&rft_dat=%3Cproquest_pubme%3E2511246551%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2511246551&rft_id=info:pmid/33833480&rfr_iscdi=true |